A vaccine as a potentially safe and effective immunotherapy against CGRP Presented ByDr Jean-Cosme Dodart, Vaxxinity Inc, FL, USA TrialPhase 1, UB-313 ConferenceAAN 2023 26 June, 2023 20:04